Nippon India Pharma Fund vs Aditya Birla Sun Life Pharma and Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8357 Cr | ₹845 Cr |
Min Investment | ₹5000 | ₹1000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 10 Jul 2019 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 21% | 31% |
Expense Ratio | 1.82 | 2.27 |
Manager | Sailesh Raj Bhan | Dhaval Joshi |
ISIN Code | INF204K01968 | INF209KB1N91 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
1 Month | -0.91% | -0.48% |
6 Month | 5.43% | 5.5% |
1 Year | -1.62% | -2.62% |
3 Year | 22.08% | 21.98% |
5 Year | 17.44% | 15.55% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
6 Month | -0.13% | 1.39% |
1 Year | 4.99% | 7.06% |
3 Year | 18.87% | 19.18% |
5 Year | 17.35% | 16.69% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
1 Year | 16.99% | 23.67% |
3 Year | 20.8% | 17.01% |
5 Year | 20.54% | 21.83% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Standard Deviation | 15.22% | 16.01% |
Sharp | 0.89% | 0.85% |
Beta | 0.91% | 0.96% |
Alpha | -0.46% | -1.08% |
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Name | Sailesh Raj Bhan | Dhaval Joshi |
Total AUM | ₹96086 Cr | ₹361932 Cr |
Funds Managed | 5 | 55 |
Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Others | 1.52 | 4.88 |
Large Cap | 33.27 | 25.69 |
Mid Cap | 33.86 | 41.06 |
Small Cap | 31.35 | 28.36 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Others | 0.53 | 1.66 |
Healthcare | 99.47 | 97.35 |
Basic Materials | - | 0.99 |
Top Comparisons
Mirae Asset Equity Savings Fund- Regular Plan- Growth
3Y Returns11.57%
Axis Equity Savings Fund - Regular Plan - Growth
3Y Returns10.43%
Bandhan Overnight Fund Regular - Growth
3Y Returns6.35%
Nippon India Overnight Fund - Regular Plan - Growth Option
3Y Returns6.38%
FRANKLIN INDIA MONEY MARKET FUND-GROWTH
3Y Returns7.51%
Bajaj Finserv Money Market Fund Regular - Growth
3Y Returns0%
BARODA BNP PARIBAS ELSS TAX SAVER FUND GROWTH- REGULAR GROWTH
3Y Returns19.19%
Quant ELSS Tax Saver Fund Regular Plan-Growth
3Y Returns15.91%